PHARMA DYNAMICS
Supplier Forensic Analysis · Scanned: 2026/07/25
Open this supplier in the workbench →These findings identify statistical unusualness and named data patterns for review. They do not establish wrongdoing and require source verification.
CIPC screening
ClearCompliance
N/A/100
Awards
4
Total Value
R 1,8B
Recent Awards
4 awards · Total: R 1 790 009 548,97
HP01-2025TB: Supply and Delivery of Anti-Tuberculosis Medicines to the Department of Health for the period 1 October 2025 to 30 September 2027
Health
Ref: HP01-2025TBR 458 432 988,39
20 Aug 2025
HP13-2025ARV: Supply and Delivery of Anti-Retroviral Medicines to the Department of Health for the period 1 July 2025 to 30 June 2028
Health
Ref: HP13-2025ARVR 899 198 367,90
20 Aug 2025
Supply and Delivery of Anti-Tuberculosis Medicines to the Department of Health for the period ending 30 September 2025
Health
Ref: HP01-2023TB/01R 160 980 288,00
26 Jul 2024
SUPPLY AND DELIVERY OF ANTI-TUBERCULOSIS MEDICINES TO THE DEPARTMENT OF HEALTH FOR THE PERIOD 1 OCTOBER 2023 TO 30 SEPTEMBER 2025
Health
Ref: HP01-2023TBR 271 397 904,68
12 Jun 2023
AI Analysis
Powered by GeminiAI Forensic Analysis
Get AI-generated audit narratives with key findings and recommended actions.
Paid access from R499/mo
or upgrade to Pro Subscription
Procurement context
Competitive concentration, procurement-intelligence context, province health, and restricted-supplier status are available to forensic subscribers.
Unlock forensic context →CIPC screening signalsClear
No contributing warning signals in the current evidence.
Unlock Full Analysis
Get access to all forensic flags, evidence details, and AI-generated audit narratives.
View Full Intelligence Report
Get complete award history, director network, and compliance analysis.
View Report →